SCHEMBL514724

SCHEMBL514724

C=CCCCCCCC(=O)OCCC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.62
LMNA P02545 2/20 0.62
TSHR P16473 3/20 0.59
DGKA P23743 2/20 0.58
MAPT P10636 3/20 0.50
ABCC4 O15439 1/20 0.50
DNM1 Q05193 1/20 0.49
MGLL Q99685 1/20 0.46
THRB P10828 1/20 0.45
CNR1 P21554 1/20 0.45
CYP3A4 P08684 2/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
PAM P19021 2/20 0.44
USP2 O75604 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
PRSS1 P07477 1/20 0.43
PRSS2 P07478 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15758052 1.00 ALDH1A1 (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL3694489 1.00 ALDH1A1 (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL514908 1.00 ALDH1A1 (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL6434039 1.00 ALDH1A1 (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL515243 0.98 ALDH1A1 (0.59) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL514827 0.93 TSHR (0.53) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL14763919 0.91 TSHR (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL3111539 0.91 TSHR (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL515244 0.91 TSHR (0.62) ALDH1A1LMNATSHRDGKAMAPT
SCHEMBL514084 0.91 TSHR (0.62) ALDH1A1LMNATSHRDGKAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190284152-A1 Maleinated Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2019-09-19 US disclosed
US-10294210-B2 Maleinated derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2019-05-21 US disclosed
US-20180111912-A1 Maleinated Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2018-04-26 US disclosed
US-9896424-B2 Methods of making sulfurized derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2018-02-20 US disclosed
US-9738618-B2 Malienated derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2017-08-22 US disclosed
US-20160355492-A1 Methods of Making Sulfurized Derivatives ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-12-08 US disclosed
CN-103562362-B The monomer of functionalization 艾勒旺斯可再生科学公司 2016-09-14 CN disclosed
US-9334347-B2 Functionalized monomers and polymers ELEVANCE RENEWABLE SCIENCES, INC. (US) 2016-05-10 US disclosed
US-9012385-B2 Terpene derived compounds ELEVANCE RENEWABLE SCIENCES, INC. (US) 2015-04-21 US disclosed
US-20140357539-A1 FUNCTIONALIZED MONOMERS AND POLYMERS WILMAR TRADING PTE LTD (SG) 2014-12-04 US disclosed
WO-2012129479-A2 MALIENATED DERIVATIVES ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129477-A1 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129482-A2 FUNCTIONALIZED MONOMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
WO-2012129490-A2 FUNCTIONALIZED POLYMERS ELEVANCE RENEWABLE SCIENCES (US) 2012-09-27 WO disclosed
US-20120245063-A1 FUNCTIONALIZED MONOMERS AND POLYMERS WILMAR TRADING PTE LTD (SG) 2012-09-27 US disclosed
CN-102369173-A Method for producing high-purity terminal olefin compound KURARAY CO 2012-03-07 CN disclosed
EP-2415740-A1 METHOD FOR PRODUCING HIGH-PURITY TERMINAL OLEFIN COMPOUND Kuraray Co., Ltd. (JP) 2012-02-08 EP disclosed
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND KURARAY CO., LTD. (JP) 2012-02-02 US disclosed
US-4260552-A INSECTICIDES, HERBICIDES UNIROYAL, INC. (US) 1981-04-07 US disclosed
US-4160846-A Method for controlling insects with tetrasubstituted organotin compounds UNIROYAL, INC. (US) 1979-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180111912-A1 Maleinated Derivatives SMOX, SRM, PADI2 ALDH1A1 383/4885LMNA 1847/4885TSHR 4723/4885
US-20120245063-A1 FUNCTIONALIZED MONOMERS AND POLYMERS PUF60, FGB, MSN ALDH1A1 562/4885LMNA 2878/4885TSHR 4545/4885
US-20190284152-A1 Maleinated Derivatives SMOX, SRM, PADI2 ALDH1A1 383/4885LMNA 1847/4885TSHR 4723/4885
US-20120029229-A1 METHOD FOR PRODUCING HIGH PURITY TERMINAL OLEFIN COMPOUND ADH1A, ADH1C, OSBP ALDH1A1 233/4885LMNA 3696/4885TSHR 3218/4885
US-20160355492-A1 Methods of Making Sulfurized Derivatives GPX4, CBS, ESD ALDH1A1 769/4885LMNA 4738/4885TSHR 4776/4885
US-10294210-B2 Maleinated derivatives SMOX, SRM, PADI2 ALDH1A1 385/4885LMNA 1892/4885TSHR 4719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.